401 related articles for article (PubMed ID: 33613102)
1. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer.
Tang J; Tian Z; Liao X; Wu G
Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102
[TBL] [Abstract][Full Text] [Related]
2. ATXN3 promotes prostate cancer progression by stabilizing YAP.
Wu L; Ou Z; Liu P; Zhao C; Tong S; Wang R; Li Y; Yuan J; Chen M; Fan B; Zu X; Wang Y; Tang J
Cell Commun Signal; 2023 Jun; 21(1):152. PubMed ID: 37349820
[TBL] [Abstract][Full Text] [Related]
3. Sex-determining Region Y-box transcription factor 13 promotes breast cancer cell proliferation and glycolysis by activating the tripartite motif containing 11-mediated Wnt/β-catenin signaling pathway.
Jin X; Shao X; Pang W; Wang Z; Huang J
Bioengineered; 2022 May; 13(5):13033-13044. PubMed ID: 35611828
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway.
Tang J; Yang Q; Mao C; Xiao D; Liu S; Xiao L; Zhou L; Wu G; Tao Y
Cell Death Differ; 2023 May; 30(5):1247-1259. PubMed ID: 36813921
[TBL] [Abstract][Full Text] [Related]
5. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G
Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554
[TBL] [Abstract][Full Text] [Related]
6. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma.
Wang Z; Qiu X; Zhang H; Li W
J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973
[TBL] [Abstract][Full Text] [Related]
7. TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination.
Zhang P; Tang Y; Zhao J; Yang J; Chen Y; Gong Y; Meng S; Shu C
Neoplasma; 2023 Oct; 70(5):659-669. PubMed ID: 38053376
[TBL] [Abstract][Full Text] [Related]
8. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
10. MINDY1 promotes bladder cancer progression by stabilizing YAP.
Luo Y; Zhou J; Tang J; Zhou F; He Z; Liu T; Liu T
Cancer Cell Int; 2021 Jul; 21(1):395. PubMed ID: 34315490
[TBL] [Abstract][Full Text] [Related]
11. Tripartite motif-containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin-proteasome-mediated degradation of pleckstrin homology domain leucine-rich repeats protein phosphatase 1.
Yang J; Ye J; Ma T; Tang F; Huang L; Liu Z; Tian S; Cheng X; Zhang L; Guo Z; Tu F; He M; Xu X; Lu X; Wu Y; Zeng X; Zou J; Wang X; Peng W; Zhang P
Hepatology; 2022 Sep; 76(3):612-629. PubMed ID: 34767673
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.
Yan P; Su Z; Zhang Z; Gao T
Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599
[TBL] [Abstract][Full Text] [Related]
13. TRIM11, a new target of p53, facilitates the migration and invasion of nasopharyngeal carcinoma cells.
Zhao Z; Deng J; Lu M; Yang J; Chen L; Li D; Sang Y
Mol Biol Rep; 2023 Jan; 50(1):731-737. PubMed ID: 36376537
[TBL] [Abstract][Full Text] [Related]
14. HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
Pan Z; Fang Q; Li L; Zhang Y; Xu T; Liu Y; Zheng X; Tan Z; Huang P; Ge M
Cancer Lett; 2021 Mar; 501():31-42. PubMed ID: 33359451
[TBL] [Abstract][Full Text] [Related]
15. TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells.
Wang X; Shi W; Shi H; Lu S; Wang K; Sun C; He J; Jin W; Lv X; Zou H; Shu Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):100. PubMed ID: 27329103
[TBL] [Abstract][Full Text] [Related]
16. The EPRS-ATF4-COLI pathway axis is a potential target for anaplastic thyroid carcinoma therapy.
Mi L; Liu J; Zhang Y; Su A; Tang M; Xing Z; He T; Wei T; Li Z; Wu W
Phytomedicine; 2024 Jul; 129():155670. PubMed ID: 38704915
[TBL] [Abstract][Full Text] [Related]
17. Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.
Zhu X; Park S; Lee WK; Cheng SY
Endocr Relat Cancer; 2019 Sep; 26(9):739-750. PubMed ID: 31272080
[TBL] [Abstract][Full Text] [Related]
18. USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ.
Tang J; Luo Y; Xiao L
Cell Death Dis; 2022 Apr; 13(4):326. PubMed ID: 35397626
[TBL] [Abstract][Full Text] [Related]
19. Signal transducer and activator of transcription 3 inhibition alleviates resistance to BRAF inhibition in anaplastic thyroid cancer.
Wang Y; Hu Z; Ma W; Niu Y; Su J; Zhang L; Zhao P
Invest New Drugs; 2021 Jun; 39(3):764-774. PubMed ID: 33245464
[TBL] [Abstract][Full Text] [Related]
20. Tripartite Motif-containing Protein 11 Silencing Inhibits Proliferation and Glycolysis and Promotes Apoptosis of Esophageal Squamous Cell Carcinoma Cells by Inactivating Signal Transduction and Activation of Transcription Factor 3/c-Myc Signaling.
Xuan T
; 2024 Jan; 67(1):37-46. PubMed ID: 38780271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
